These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1842010)

  • 1. The effectiveness of tipi in the treatment of hip and knee osteoarthritis--a preliminary report.
    Ferraz MB; Pereira RB; Coelho Andrade LE; Atra E
    Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():241-3. PubMed ID: 1842010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-to-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study.
    Sanga P; Katz N; Polverejan E; Wang S; Kelly KM; Haeussler J; Thipphawong J
    Arthritis Rheumatol; 2017 Apr; 69(4):763-773. PubMed ID: 27748055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.
    DeLemos BP; Xiang J; Benson C; Gana TJ; Pascual ML; Rosanna R; Fleming B
    Am J Ther; 2011 May; 18(3):216-26. PubMed ID: 20215961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
    Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
    Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
    Hale M; Tudor IC; Khanna S; Thipphawong J
    Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial.
    Blotman F; Maheu E; Wulwik A; Caspard H; Lopez A
    Rev Rhum Engl Ed; 1997 Dec; 64(12):825-34. PubMed ID: 9476272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of individualized Chinese herbal medication in osteoarthrosis of hip and knee: a double-blind, randomized-controlled clinical study.
    Lechner M; Steirer I; Brinkhaus B; Chen Y; Krist-Dungl C; Koschier A; Gantschacher M; Neumann K; Zauner-Dungl A
    J Altern Complement Med; 2011 Jun; 17(6):539-47. PubMed ID: 21649520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tipi. A popular analgesic tea: a double-blind cross-over trial in osteoarthritis.
    Ferraz MB; Pereira RB; Iwata NM; Atra E
    Clin Exp Rheumatol; 1991; 9(2):205-6. PubMed ID: 2060165
    [No Abstract]   [Full Text] [Related]  

  • 10. Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial.
    Brown MT; Murphy FT; Radin DM; Davignon I; Smith MD; West CR
    Arthritis Rheum; 2013 Jul; 65(7):1795-803. PubMed ID: 23553790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double blind, randomized, placebo controlled study to evaluate the efficacy of erythromycin in patients with knee effusion due to osteoarthritis.
    Sadreddini S; Noshad H; Molaeefard M; Moloudi R; Ardalan MR; Ghojazadeh M
    Int J Rheum Dis; 2009 Apr; 12(1):44-51. PubMed ID: 20374316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study.
    Emery P; Koncz T; Pan S; Lowry S
    Clin Ther; 2008 Jan; 30(1):70-83. PubMed ID: 18343244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot randomized, placebo-controlled clinical trial to investigate the efficacy and safety of an extract of Artemisia annua administered over 12 weeks, for managing pain, stiffness, and functional limitation associated with osteoarthritis of the hip and knee.
    Stebbings S; Beattie E; McNamara D; Hunt S
    Clin Rheumatol; 2016 Jul; 35(7):1829-36. PubMed ID: 26631103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee.
    Peloso PM; Bellamy N; Bensen W; Thomson GT; Harsanyi Z; Babul N; Darke AC
    J Rheumatol; 2000 Mar; 27(3):764-71. PubMed ID: 10743822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect.
    Maheu E; Mazières B; Valat JP; Loyau G; Le Loët X; Bourgeois P; Grouin JM; Rozenberg S
    Arthritis Rheum; 1998 Jan; 41(1):81-91. PubMed ID: 9433873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of the OARSI-OMERACT osteoarthritis pain and function measures.
    Bond M; Davis A; Lohmander S; Hawker G
    Osteoarthritis Cartilage; 2012 Jun; 20(6):541-7. PubMed ID: 22425883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter studies in the United States and Canada of meclofenamate sodium in osteoarthritis of the hip and knee. Double-blind comparison with placebo and long-term experience.
    Petrick TJ; Bovenkerk WE
    Arzneimittelforschung; 1983; 33(4A):644-8. PubMed ID: 6349649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis.
    Prior MJ; Harrison DD; Frustaci ME
    Curr Med Res Opin; 2014 Nov; 30(11):2377-87. PubMed ID: 25121804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee.
    Pincus T; Koch GG; Sokka T; Lefkowith J; Wolfe F; Jordan JM; Luta G; Callahan LF; Wang X; Schwartz T; Abramson SB; Caldwell JR; Harrell RA; Kremer JM; Lautzenheiser RL; Markenson JA; Schnitzer TJ; Weaver A; Cummins P; Wilson A; Morant S; Fort J
    Arthritis Rheum; 2001 Jul; 44(7):1587-98. PubMed ID: 11465710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Gana TJ; Pascual ML; Fleming RR; Schein JR; Janagap CC; Xiang J; Vorsanger GJ;
    Curr Med Res Opin; 2006 Jul; 22(7):1391-401. PubMed ID: 16834838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.